Thursday, February 3, 2005
Valeant Buys Xcel For $280M
San Diego-based Xcel Pharmaceuticals was acquired yesterday by Valeant Pharmaceuticals for $280M, in an all cash deal. Xcel has a number of products for the treatment of epilepsy and acute migraine headaches. The deal also calls for Valeant to retire $44M in Xcel debt. Valeant said that it would use Xcel to boost its North American business and neurology offerings.
Get More SocalTech Data
Try our two week free trial to find new tech customers, find high tech startups and jobs, find venture funding, and more!Learn More